Vous êtes ici

MindBio Therapeutics Corp.

Liste d'échange: 
CSE
Statut: 
Active
Industrie: 
Life Sciences
Symbole: 
MBIO
Indice CSE: 
No
Devise: 
CAD

MindBio is a clinical stage biopharmaceutical company targeting depressive illnesses currently dosing in multiple Phase 2B clinical trials.  MB22001 is MindBio’s lead candidate drug, a proprietary titratable form of Lysergic Acid Diethylamide (LSD) designed for take-home microdosing.  MindBio is a leader in microdosing of psychedelic medicines and is advancing its drug and technology protocols through clinical trials. MindBio has developed a multi-disciplinary platform for developing treatments and is involved in psychedelic medicine development and digital therapeutics, has completed a large Phase 1 randomised controlled trial in 80 healthy participants and has completed a Phase 2a Open Label clinical trial in patients with Major Depressive Disorder, both trials with positive top line data reported.  Currently underway are two Phase 2B trials, one in cancer patients experiencing existential distress and another in patients with Major Depressive Disorder due for completion late 2025.  The Company is also approved for multiple Phase 1/Phase 2B trials in women’s health. MindBio invests in research that forms the basis for developing novel and clinically proven treatments including digital technologies and interventions to treat debilitating health conditions such as depression, anxiety and other related mental health conditions.

MindBio Therapeutics Corp. (MBIO)

0.01
0.00 (0.00%)

MindBio Therapeutics Corp. (MBIO)

*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.

Citation

Quantité demandé
1,834,000 
Cours acheteur
0.005 
Cours vendeur
0.01 
Quantité offerte
245,000 
Volume
29,086 
Dernier prix
0.01 
Écart minimum
Up 
variation nette
 
Clôture précédente
0.01 
Ouverture
0.01 
Day High
0.01 
Day Low
0.01 
Haut 52 semaines
0.07 
Bas 52 semaines
0.005 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Quantité demandé
Cours acheteur
0.00 
Cours vendeur
0.00 
Quantité offerte
Volume
Dernier prix
0.02 
Écart minimum
Up 
variation nette
 
Clôture précédente
0.02 
Ouverture
0.00 
Day High
0.00 
Day Low
0.00 
Haut 52 semaines
 
Bas 52 semaines
 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Citation

Quantité demandé
1,834,000 
Cours acheteur
0.005 
Cours vendeur
0.01 
Quantité offerte
245,000 
Volume
29,086 
Dernier prix
0.01 
Écart minimum
Up 
variation nette
 
Clôture précédente
0.01 
Ouverture
0.01 
Day High
0.01 
Day Low
0.01 
Haut 52 semaines
0.07 
Bas 52 semaines
0.005 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Quantité demandé
Cours acheteur
0.00 
Cours vendeur
0.00 
Quantité offerte
Volume
Dernier prix
0.02 
Écart minimum
Up 
variation nette
 
Clôture précédente
0.02 
Ouverture
0.00 
Day High
0.00 
Day Low
0.00 
Haut 52 semaines
 
Bas 52 semaines
 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Profondeur de marche par ordre

  • MBIO / Dernière mise à jour: 15:22:13 ET
  • Refresh
  • Info
Courtier Bid Quantité demandé Cours acheteur Cours vendeur Quantité offerte Demandez Broker
Desjardins Securities Inc. 27,000 0.005 0.01 243,000 Anonymous
RBC Capital Markets 200,000 0.005 0.01 2,000 Desjardins Securities Inc.
National Bank Financial Inc. 113,000 0.005 0.015 87,000 BMO Nesbitt Burns Inc.
CIBC World Markets Inc. 33,000 0.005 0.015 7,000 National Bank Financial Inc.
BMO Nesbitt Burns Inc. 280,000 0.005 0.015 29,000 National Bank Financial Inc.
Desjardins Securities Inc. 50,000 0.005 0.015 5,000 Scotia Capital Inc.
Desjardins Securities Inc. 16,000 0.005 0.015 10,000 Scotia Capital Inc.
Desjardins Securities Inc. 90,000 0.005 0.015 10,000 CIBC World Markets Inc.
TD Securities Inc. 20,000 0.005 0.015 47,000 National Bank Financial Inc.
RBC Capital Markets 60,000 0.005 0.02 25,000 BMO Nesbitt Burns Inc.
Courtier Bid Quantité demandé Cours acheteur Cours vendeur Quantité offerte Demandez Broker
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0

Profondeur d'affichage de prix

  • MBIO / Dernière mise à jour: 15:22:13 ET
  • Refresh
  • Info
Acheteur Quantité demandé Cours acheteur Cours vendeur Quantité offerte Vendeur
22 1,834,000 0.005 0.01 245,000 2
0 0 0.00 0.015 195,000 7
0 0 0.00 0.02 227,000 7
0 0 0.00 0.025 56,000 3
0 0 0.00 0.03 133,000 6
Acheteur Quantité demandé Cours acheteur Cours vendeur Quantité offerte Vendeur
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0

Métiers récents

  • MBIO / Dernière mise à jour: 14:12:28 ET
  • Refresh
  • Info
Date/Heure Prix Modifier Volume Acheteur Vendeur Venue
Apr 11, 18:12 0.01 0.00 10,000 CIBC World Markets Inc. Anonymous CSE
Apr 11, 13:51 0.01 0.00 5,000 Scotia Capital Inc. Anonymous CSE
Apr 11, 13:43 0.01 0.00 5,000 Scotia Capital Inc. Anonymous CSE
Apr 11, 13:34 0.01 0.00 2,000 Questrade Inc. Anonymous CSE
Apr 11, 13:30 0.01 0.00 7,000 National Bank Financial Inc. Anonymous CSE

Information d'entreprise

Addresse
1055 West Georgia Street,1500 Royal Centre P.O Box 11117
Vancouver, BC V6E 4N7
Canada
Téléphone
+61 4331140886
Courriel
justin@mindbiotherapeutics.com
URL
https://www.mindbiotherapeutics.com
Date d’inscription à la cote
Vendredi, mai 5, 2023
Agent de transfert
Odyssey Trust Company
Vérificateur
MNP

SEDAR Information

Type de dossier Tout News Releases Management's Discussion & Analysis Financial Statements Material Change Report
Délai @count semaine@count mois3 month6 month@count annéeTout le temps

Information d'entreprise

Addresse
1055 West Georgia Street,1500 Royal Centre P.O Box 11117
Vancouver, BC V6E 4N7
Canada
Téléphone
+61 4331140886
Courriel
justin@mindbiotherapeutics.com
URL
https://www.mindbiotherapeutics.com
Date d’inscription à la cote
Vendredi, mai 5, 2023
Agent de transfert
Odyssey Trust Company
Vérificateur
MNP

Capitalisation

Capitalisation: 
177957291
Réservé à l'émission: 
12127309

Company Officers

Justin Hanka, Chief Executive Officer and Director
Gavin Upiter, Non-Executive Director and Chairman
Dr Zena Burgess, Non Executive Director